GlassScriptPhysician profile
Shifa Akhtar
NPI 1902548175
$2,870.91
in general payments reported to CMS, 2019-2025
18 companies · $508 in 2025
The $508 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $262 · 2023: $497 · 2024: $1,604 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,514 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,513.69 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $435.46 | 2023-2024 | Skyrizi |
| Janssen Biotech, INC. | $307.66 | 2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $275.58 | 2022-2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $269.38 | 2022-2025 | Dupixent, Libtayo |
| Incyte Corporation | $241.63 | 2025 | Opzelura, Opzelura |
| Ucb, INC. | $211.74 | 2023-2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $182.99 | 2024 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.32 | 2024 | Spevigo |
| Merz North America, INC. | $171.86 | 2024 | |
| Mimedx Group, INC. | $130.76 | 2024 | |
| Krystal Biotech INC | $124.99 | 2023 | Vyjuvek |
| Amgen INC. | $76.57 | 2023-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $68.04 | 2023-2024 | Ilumya |
| Helsinn Therapeutics (U.S.), INC. | $56.50 | 2022-2023 | Valchlor |
| Pfizer INC. | $46.09 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $42.29 | 2023-2025 | |
| Organon LLC | $31.05 | 2025 | Vtama |
| Biofrontera INC. | $21.00 | 2025 | Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shifa Akhtar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.